Quality-of-Life Outcomes in Long-Term Survivors of Advanced Prostate Cancer
- 1 August 1998
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 21 (4), 327-332
- https://doi.org/10.1097/00000421-199808000-00002
Abstract
The authors evaluate the temporal progression of health-related quality of life (HRQOL) in men treated hormonally with surgical or medical castration, as well as to see if either treatment would be associated with a greater impact on patients' quality of life. The authors assessed general and prostate-targeted HRQOL with two self-administered, validated instruments (the RAND 36-Item Health Survey and the UCLA Prostate Cancer Index) in a longitudinal, observational study of 63 men newly diagnosed with metastatic prostate cancer and treated with bilateral orchiectomy or combined androgen blockade with leuprolide and flutamide. Patients completed the two HRQOL instruments by mail at baseline and at 3- and 6-month intervals after initiation of treatment. Significant improvements were demonstrated in 10 of 14 HRQOL domains for all men during the first 12 months. These include all eight of the general HRQOL domains and the disease-specific domains that address bowel function. The authors identified no differences in any of the general or prostate-targeted HRQOL domains when comparing men who underwent orchiectomy versus combined androgen blockade. Patients with metastatic prostate cancer can be informed that general and prostate-specific HRQOL will be similar, regardless of whether they choose medical or surgical castration, and that health status will likely remain stable or improve during the initial months of treatment. Physicians must make patients aware of both the quantity and quality of life they can expect with advanced prostate cancer, and must actively involve them in their treatment decisions.Keywords
This publication has 16 references indexed in Scilit:
- Marriage and Mortality in Prostate CancerJournal of Urology, 1996
- The relationship between sexual life and urinary condition in the French communityJournal of Clinical Epidemiology, 1996
- Quality-of-life outcomes in men treated for localized prostate cancerJAMA, 1995
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Quality of life and psychosocial status in stage D prostate cancerQuality of Life Research, 1992
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Sex or survival: trade-offs between quality and quantity of life.Journal of Clinical Oncology, 1991
- Measurement of health statusControlled Clinical Trials, 1989
- Patients' choice of treatment in stage D prostate cancerUrology, 1989
- Coefficient alpha and the internal structure of testsPsychometrika, 1951